SEC ownership of Accustem Sciences Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001850767.

Comparable stake leader

Gabriele M. Cerrone

Disclosed value leader

Gabriele M. Cerrone

Comparable rows

0/4

Latest evidence

13 Jun 2025

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 1 signal
Latest parsed ownership date
13 Jun 2025
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001850767
Issuer location
New York, NY

Ownership snapshot

Top shareholders of Accustem Sciences Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Gabriele M. Cerrone
Disclosed value leader
Gabriele M. Cerrone
Comparable rows
0/4
Latest evidence
13 Jun 2025
3/4/5 Highest disclosed value: $7,152,640 4 rows are not safely comparable across share classes.

Quick read

Gabriele M. Cerrone has the largest disclosed position value at $7.15M.

0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Gabriele M. Cerrone's linked filing trail.
Disclosed position value Top 4
Gabriele M. Cerrone $7.15M
Kunwar Shailubhai $14.2K
Wendy E. Blosser $2.8K
Willy Jules Simon $578

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-4 of 4 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Gabriele M. Cerrone
3/4/5
Director, 10%+ Owner
class O/S missing
$7,152,640
6,502,400 shares
13 Jun 2025
Kunwar Shailubhai
3/4/5
Director
class O/S missing
$14,175
10,125 shares
01 Dec 2021
Wendy E. Blosser
3/4/5
Chief Executive Officer, Director
class O/S missing
$2,800
2,000 shares
04 Mar 2022
Willy Jules Simon
3/4/5
Director
class O/S missing
$578
413 shares
01 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 15 Jun 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-6 of 6 reporting-owner rows connected to Accustem Sciences Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
6
Largest Forms 3/4/5 holder
Gabriele M. Cerrone
Net 12M change
$0
Latest report
13 Jun 2025
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Gabriele M. Cerrone Director, 10%+ Owner $7,152,640 Filing P/S 13 Jun 2025
Kunwar Shailubhai Director $14,175 Mixed 01 Dec 2021
Wendy E. Blosser Chief Executive Officer, Director $2,800 Mixed 04 Mar 2022
Willy Jules Simon Director $578 Mixed 01 Dec 2021
John P. Brancaccio Director Mixed 01 Dec 2021
Keeren Shah Chief Financial Officer Mixed 01 Dec 2021

Recent insider transactions for Accustem Sciences Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .